相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment
Xin Ying Chua et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
Yuek Ling Chai et al.
BRAIN PATHOLOGY (2019)
Molecular biomarkers of Alzheimer's disease: progress and prospects
Tammaryn Lashley et al.
DISEASE MODELS & MECHANISMS (2018)
Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice
Hongxia Che et al.
FOOD & FUNCTION (2018)
The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain
Jia Pei Chan et al.
PLOS BIOLOGY (2018)
Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease
Min Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load
Joyce R. Chong et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Perinatal Brain Docosahexaenoic Acid Concentration Has a Lasting Impact on Cognition in Mice
Luis E. Lozada et al.
JOURNAL OF NUTRITION (2017)
Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies
Mathieu Bourdenx et al.
PROGRESS IN NEUROBIOLOGY (2017)
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Erika Bereczki et al.
ALZHEIMERS & DEMENTIA (2016)
Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease
David Heras-Sandoval et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease
Mounir Belkouch et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease
Rawan Tarawneh et al.
JAMA NEUROLOGY (2016)
Alzheimer's Association Report 2015 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2015)
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease
Erik Portelius et al.
BRAIN (2015)
Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid
Yijun Pan et al.
MOLECULAR PHARMACEUTICS (2015)
Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome
Alicia Guemez-Gamboa et al.
NATURE GENETICS (2015)
Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA
Simon C. Dyall
FRONTIERS IN AGING NEUROSCIENCE (2015)
Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
David R. Howlett et al.
BRAIN PATHOLOGY (2015)
Glia in the pathogenesis of neurodegenerative diseases
Alexei Verkhratsky et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Long N. Nguyen et al.
NATURE (2014)
The brain lipidomes of subcortical ischemic vascular dementia and mixed dementia
Sin Man Lam et al.
NEUROBIOLOGY OF AGING (2014)
Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with A beta burden
Michelle G. K. Tan et al.
NEUROCHEMISTRY INTERNATIONAL (2014)
Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry
John F. Kellie et al.
SCIENTIFIC REPORTS (2014)
DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease
Dai Yuki et al.
SCIENTIFIC REPORTS (2014)
The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease
Marcus O. W. Grimm et al.
BIOMED RESEARCH INTERNATIONAL (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
Thomas J. Montine et al.
ACTA NEUROPATHOLOGICA (2012)
Brain amyloid and cognition in Lewy body diseases
Stephen N. Gomperts et al.
MOVEMENT DISORDERS (2012)
Serum ceramides increase the risk of Alzheimer disease The Women's Health and Aging Study II
Michelle M. Mielke et al.
NEUROLOGY (2012)
Amyloid oligomers: formation and toxicity of A beta oligomers
Masafumi Sakono et al.
FEBS JOURNAL (2010)
Neurogranin, a Link Between Calcium/Calmodulin and Protein Kinase C Signaling in Synaptic Plasticity
F. Javier Diez-Guerra
IUBMB LIFE (2010)
Fatty Acid Composition of Frontal, Temporal and Parietal Neocortex in the Normal Human Brain and in Alzheimer's Disease
Thomas Fraser et al.
NEUROCHEMICAL RESEARCH (2010)
Use of Phosphatide Precursors to Promote Synaptogenesis
Richard J. Wurtman et al.
Annual Review of Nutrition (2009)
An n-3 Fatty Acid Deficiency Impairs Rat Spatial Learning in the Barnes Maze
Irina Fedorova et al.
BEHAVIORAL NEUROSCIENCE (2009)
Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function
Dehua Cao et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria
Dag Aarsland et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)
Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography
P. Edison et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils
M. Cansev et al.
NEUROSCIENCE (2007)
Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels
Kim N. Green et al.
JOURNAL OF NEUROSCIENCE (2007)
Soluble protein oligomers in neurodegeneration:: lessons from the Alzheimer's amyloid β-peptide
Christian Haass et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
A systematic review of prevalence and incidence studies of dementia with Lewy bodies
J Zaccai et al.
AGE AND AGEING (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
分享论文
